C. DIFF INFECTION

Clinical trials for C. DIFF INFECTION explained in plain language.

Never miss a new study

Get alerted when new C. DIFF INFECTION trials appear

Sign up with your email to follow new studies for C. DIFF INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to stop debilitating gut infection from coming back

Prevention Recruiting now

This study is testing whether a 14-day course of an investigational oral drug called VE303 can prevent a C. difficile infection from coming back after standard antibiotic treatment. It will enroll 852 people who have just been treated for a C. diff infection and are at high risk …

Matched conditions: C. DIFF INFECTION

Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention

Last updated Mar 12, 2026 13:51 UTC

C. DIFF INFECTION

Get alerted when new C. DIFF INFECTION trials appear

New drug aims to stop debilitating gut infection from coming back